Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
RELIEF THERAPEUTICS Holding SA reported its financial results for the full-year ended December 31, 2022 and provided a corporate update.
Uncategorized
Hansa Biopharma to host conference call to provide interim results for January-March 2023 and a Business Update
Hansa Biopharma AB will publish its interim report for January-March 2023 at 8:00 CET on April 20, 2023.
JEOL: Release of Cryogen Reclamation System
JEOL Ltd. announces launch of a new Cryogen Reclamation System for Nuclear Magnetic Resonance on April 14, 2023.
Alvotech Provides Regulatory Update on AVT02 Biologics License Application
Alvotech announced that the U.S. Food and Drug Administration has issued a complete response letter for Alvotech’s Biologics License Application for AVT02, a high-concentration biosimilar candidate for Humira®.
Alvotech Provides Regulatory Update on AVT02 Biologics License Application Read More »
Additional Future Royalty Revenue Stream for Nicox from 2024 following New Drug Application Submission for ZERVIATE in China
Nicox SA, an international ophthalmology company, announced that its exclusive Chinese partner, Ocumension Therapeutics, has submitted a New Drug Application for approval to commercialize ZERVIATE®, 0.24%, in China, for ocular itching associated with allergic conjunctivitis.
Complete Response Letter Received for AVT02 Biologics License Application
Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration has issued a complete response letter to its partner Alvotech for the Biologics License Application for AVT02, a high-concentration biosimilar candidate for Humira®.
Complete Response Letter Received for AVT02 Biologics License Application Read More »
Moody’s report highlights need for healthcare investment in cybersecurity
The ratings agency said healthcare’s vulnerable state makes it “target rich,” which could bring service disruptions and personal data disclosures.
Moody’s report highlights need for healthcare investment in cybersecurity Read More »
Appeals court rules abortion drug can stay on market — but limits access
The order is the latest twist in an escalating legal battle over access to mifepristone, a fight that is headed to the Supreme Court.
Appeals court rules abortion drug can stay on market — but limits access Read More »
Treatment Approach to Depression Sees Paradigm Shift
New therapeutics for Major Depressive Disorder could change the treatment landscape and give patients more options.
Treatment Approach to Depression Sees Paradigm Shift Read More »
Advocate Aurora is latest nonprofit in the red, posts $751M net loss in 2022
Climbing expenses and investment losses contributed to the drop, compared with net income of $1.8 billion in 2021.
Advocate Aurora is latest nonprofit in the red, posts $751M net loss in 2022 Read More »